USD 1.2
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | - ILS | 0.0% |
2022 | - ILS | 0.0% |
2021 | - ILS | 0.0% |
2020 | - ILS | -100.0% |
2019 | 296.87 Million ILS | 5.8% |
2018 | 280.59 Million ILS | -72.6% |
2017 | 1.02 Billion ILS | -48.32% |
2016 | 1.98 Billion ILS | -8.71% |
2015 | 2.17 Billion ILS | -17.55% |
2014 | 2.63 Billion ILS | -41.12% |
2013 | 4.47 Billion ILS | -14.22% |
2012 | 5.21 Billion ILS | -33.96% |
2011 | 7.89 Billion ILS | -0.97% |
2010 | 7.97 Billion ILS | 21.92% |
2009 | 6.53 Billion ILS | 16.28% |
2008 | 5.62 Billion ILS | 30.71% |
2007 | 4.3 Billion ILS | 797.32% |
2006 | 479.34 Million ILS | -79.32% |
2005 | 2.31 Billion ILS | -21.71% |
2004 | 2.96 Billion ILS | -20.89% |
2003 | 3.74 Billion ILS | -3.71% |
2002 | 3.88 Billion ILS | 42.29% |
2001 | 2.73 Billion ILS | 56.32% |
2000 | 1.74 Billion ILS | 72.45% |
1999 | 1.01 Billion ILS | 914.9% |
1998 | 99.85 Million ILS | -78.48% |
1997 | 464.05 Million ILS | 49.25% |
1996 | 310.91 Million ILS | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | - ILS | 0.0% |
2024 Q1 | - ILS | 0.0% |
2023 Q3 | - ILS | 0.0% |
2023 Q2 | - ILS | 0.0% |
2023 FY | - ILS | 0.0% |
2023 Q1 | - ILS | 0.0% |
2023 Q4 | - ILS | 0.0% |
2022 Q1 | - ILS | 0.0% |
2022 Q3 | - ILS | 0.0% |
2022 Q2 | - ILS | 0.0% |
2022 Q4 | - ILS | 0.0% |
2022 FY | - ILS | 0.0% |
2021 Q3 | - ILS | 0.0% |
2021 Q4 | - ILS | 0.0% |
2021 Q2 | - ILS | 0.0% |
2021 FY | - ILS | 0.0% |
2021 Q1 | - ILS | 0.0% |
2020 Q4 | - ILS | 0.0% |
2020 Q1 | 4.07 Million ILS | -98.63% |
2020 Q2 | 4.07 Million ILS | 0.0% |
2020 Q3 | - ILS | -100.0% |
2020 FY | - ILS | -100.0% |
2019 Q1 | - ILS | -100.0% |
2019 FY | 296.87 Million ILS | 5.8% |
2019 Q3 | 287.92 Million ILS | 0.0% |
2019 Q4 | 296.87 Million ILS | 3.11% |
2018 Q4 | 280.59 Million ILS | 0.0% |
2018 Q1 | 670.51 Million ILS | -34.53% |
2018 Q3 | - ILS | -100.0% |
2018 Q2 | 670.51 Million ILS | 0.0% |
2018 FY | 280.59 Million ILS | -72.6% |
2017 Q4 | 1.02 Billion ILS | 0.0% |
2017 FY | 1.02 Billion ILS | -48.32% |
2017 Q1 | 1.62 Billion ILS | -17.96% |
2017 Q2 | 1.62 Billion ILS | 0.0% |
2017 Q3 | 1.02 Billion ILS | -37.0% |
2016 FY | 1.98 Billion ILS | -8.71% |
2016 Q4 | 1.98 Billion ILS | -6.52% |
2016 Q3 | 2.11 Billion ILS | -2.71% |
2016 Q2 | 2.17 Billion ILS | -2.35% |
2016 Q1 | 2.23 Billion ILS | 213.9% |
2015 Q1 | 2.52 Billion ILS | 234.55% |
2015 Q2 | 2.31 Billion ILS | -8.48% |
2015 Q3 | 2.26 Billion ILS | -2.02% |
2015 Q4 | 710.89 Million ILS | -68.64% |
2015 FY | 2.17 Billion ILS | -17.55% |
2014 Q2 | 2.77 Billion ILS | 0.36% |
2014 FY | 2.63 Billion ILS | -41.12% |
2014 Q4 | 755.53 Million ILS | -71.85% |
2014 Q3 | 2.68 Billion ILS | -3.37% |
2014 Q1 | 2.76 Billion ILS | -38.1% |
2013 FY | 4.47 Billion ILS | -14.22% |
2013 Q4 | 4.47 Billion ILS | -1.21% |
2013 Q3 | 4.52 Billion ILS | -3.72% |
2013 Q2 | 4.7 Billion ILS | -0.03% |
2013 Q1 | 4.7 Billion ILS | 0.0% |
2012 Q1 | 6.11 Billion ILS | 0.0% |
2012 Q4 | - ILS | -100.0% |
2012 Q2 | 5.86 Billion ILS | -4.06% |
2012 FY | 5.21 Billion ILS | -33.96% |
2012 Q3 | 5.45 Billion ILS | -6.94% |
2011 Q2 | 8.31 Billion ILS | -1.23% |
2011 Q1 | 8.42 Billion ILS | 0.0% |
2011 FY | 7.89 Billion ILS | -0.97% |
2011 Q4 | - ILS | -100.0% |
2011 Q3 | 8.07 Billion ILS | -3.0% |
2010 FY | 7.97 Billion ILS | 21.92% |
2010 Q2 | 8.5 Billion ILS | 26.51% |
2010 Q3 | 8.53 Billion ILS | 0.34% |
2010 Q1 | 6.72 Billion ILS | 1.05% |
2010 Q4 | - ILS | -100.0% |
2009 FY | 6.53 Billion ILS | 16.28% |
2009 Q3 | 6.36 Billion ILS | 1.47% |
2009 Q2 | 6.26 Billion ILS | 6.47% |
2009 Q1 | 5.88 Billion ILS | 4.74% |
2009 Q4 | 6.65 Billion ILS | 4.56% |
2008 FY | 5.62 Billion ILS | 30.71% |
2008 Q2 | 5.4 Billion ILS | 2.31% |
2008 Q1 | 5.28 Billion ILS | 22.94% |
2008 Q3 | 5.36 Billion ILS | -0.75% |
2008 Q4 | 5.62 Billion ILS | 4.71% |
2007 Q4 | 4.3 Billion ILS | 585.63% |
2007 Q3 | 627.35 Million ILS | -24.07% |
2007 Q2 | 826.19 Million ILS | 117.54% |
2007 Q1 | 379.79 Million ILS | -20.77% |
2007 FY | 4.3 Billion ILS | 797.32% |
2006 Q3 | 451.85 Million ILS | -9.18% |
2006 Q4 | 479.34 Million ILS | 6.09% |
2006 Q1 | 441.55 Million ILS | -80.95% |
2006 FY | 479.34 Million ILS | -79.32% |
2006 Q2 | 497.5 Million ILS | 12.67% |
2005 Q2 | 697.97 Million ILS | -77.0% |
2005 Q3 | 593.09 Million ILS | -15.03% |
2005 FY | 2.31 Billion ILS | -21.71% |
2005 Q4 | 2.31 Billion ILS | 290.9% |
2005 Q1 | 3.03 Billion ILS | 2.48% |
2004 Q2 | 3.79 Billion ILS | 0.0% |
2004 Q3 | 2.71 Billion ILS | -28.41% |
2004 FY | 2.96 Billion ILS | -20.89% |
2004 Q4 | 2.96 Billion ILS | 8.94% |
2003 Q3 | 3.55 Billion ILS | 0.91% |
2003 Q4 | 3.74 Billion ILS | 5.32% |
2003 Q1 | 3.88 Billion ILS | -0.14% |
2003 Q2 | 3.52 Billion ILS | -9.28% |
2003 FY | 3.74 Billion ILS | -3.71% |
2002 Q1 | - ILS | -100.0% |
2002 FY | 3.88 Billion ILS | 42.29% |
2002 Q2 | - ILS | 0.0% |
2002 Q4 | 3.88 Billion ILS | 2.86% |
2002 Q3 | 3.77 Billion ILS | 0.0% |
2001 Q1 | - ILS | -100.0% |
2001 Q4 | 2.73 Billion ILS | 0.0% |
2001 FY | 2.73 Billion ILS | 56.32% |
2001 Q3 | - ILS | 0.0% |
2000 FY | 1.74 Billion ILS | 72.45% |
2000 Q1 | - ILS | -100.0% |
2000 Q4 | 1.74 Billion ILS | 9.34% |
2000 Q3 | 1.59 Billion ILS | 0.0% |
2000 Q2 | - ILS | 0.0% |
1999 FY | 1.01 Billion ILS | 914.9% |
1999 Q4 | 1.01 Billion ILS | 0.0% |
1998 FY | 99.85 Million ILS | -78.48% |
1998 Q4 | 99.85 Million ILS | 0.0% |
1997 FY | 464.05 Million ILS | 49.25% |
1997 Q4 | 464.05 Million ILS | 0.0% |
1996 Q4 | 310.91 Million ILS | 0.0% |
1996 FY | 310.91 Million ILS | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
AVITA Medical, Inc. | 449.48 Thousand USD | 100.0% |
Manhattan Scientifics, Inc. | 60 Thousand USD | 100.0% |
Össur hf. | 467.73 Million USD | 100.0% |
QHSLab, Inc. | 1.78 Million USD | 100.0% |
Wellstar International, Inc. | 51.36 Million USD | 100.0% |
Össur hf. | 467.73 Million USD | 100.0% |
CVR Medical Corp. | - USD | NaN% |
Bionovate Technologies Corp | - USD | NaN% |
Escalon Medical Corp. | 524.71 Thousand USD | 100.0% |
Aurora Spine Corporation | 2.67 Million USD | 100.0% |
BrainsWay Ltd. | 471 Thousand USD | 100.0% |
Lattice Biologics Ltd. | - USD | NaN% |
BioElectronics Corporation | 14.83 Million USD | 100.0% |
Hamilton Thorne Ltd. | 27.81 Million USD | 100.0% |
Vivos Inc. | - USD | NaN% |
Kelyniam Global, Inc. | 496.39 Thousand USD | 100.0% |
REMSleep Holdings, Inc. | 178.11 Thousand USD | 100.0% |
Zecotek Photonics Inc. | 3.22 Million USD | 100.0% |
Avitar, Inc. | 5.26 Million USD | 100.0% |
Nanomix Corporation | 11.4 Million USD | 100.0% |
EKF Diagnostics Holdings plc | 5.21 Million USD | 100.0% |
Theraclion SA | 1.95 Million EUR | 100.0% |
Lifeline Biotechnologies, Inc. | - USD | NaN% |
Positron Corporation | 1.78 Million USD | 100.0% |
Rafina Innovations Inc. | - USD | NaN% |
Electromedical Technologies, Inc. | 1.69 Million USD | 100.0% |
Lombard Medical, Inc. | 32.29 Million USD | 100.0% |
ALR Technologies Inc. | 19.26 Million USD | 100.0% |
Stratec SE | 156.16 Million USD | 100.0% |
Vycor Medical, Inc. | 1.11 Million USD | 100.0% |
Heart Tronics, Inc. | 209.28 Thousand USD | 100.0% |
MicroPort Scientific Corporation | 1.69 Billion USD | 100.0% |
VMS Rehab Systems, Inc. | 133.52 USD | 100.0% |
NewCardio, Inc. | 3 Million USD | 100.0% |
Guided Therapeutics, Inc. | 2.05 Million USD | 100.0% |
Ingen Technologies, Inc. | 631.15 Thousand USD | 100.0% |
Odyssey Group International, Inc. | 2.14 Million USD | 100.0% |
CYduct Diagnostics, Inc. | 670 Thousand USD | 100.0% |
Wellness Center USA, Inc. | 4.04 Million USD | 100.0% |
SANUWAVE Health, Inc. | 31.94 Million USD | 100.0% |
IR-Med Inc. | 161 Thousand USD | 100.0% |
Perimeter Medical Imaging AI, Inc. | 192.89 Thousand USD | 100.0% |
Polarean Imaging plc | 216.38 Thousand USD | 100.0% |
United American Healthcare Corporation | - USD | NaN% |
ECGI Holdings, Inc. | 3.17 Million USD | 100.0% |
Nu-Med Plus, Inc. | 100 Thousand USD | 100.0% |
Capital Group Holdings, Inc. | 4944.00 USD | 100.0% |
ADM Tronics Unlimited, Inc. | 799.65 Thousand USD | 100.0% |
Medical Supply International USA, Inc. | 227 Thousand USD | 100.0% |
Urologix, Inc. | 5.33 Million USD | 100.0% |
Rapid Therapeutic Science Laboratories, Inc. | 3.83 Million USD | 100.0% |
Nexeon MedSystems Inc. | 4.21 Million USD | 100.0% |
SS Innovations International, Inc. | 8.21 Million USD | 100.0% |
Qualis Innovations, Inc. | 9102.00 USD | 100.0% |
Smith & Nephew plc | 3.07 Billion USD | 100.0% |
NIOX Group Plc | 1.4 Million USD | 100.0% |
Fuse Medical, Inc. | 1.99 Million USD | 100.0% |
Broncus Holding Corporation | 2.35 Million USD | 100.0% |
Brain Scientific Inc. | 2.86 Million USD | 100.0% |
Pressure BioSciences, Inc. | 22.75 Million USD | 100.0% |
Health Logic Interactive Inc. | 40.44 Thousand USD | 100.0% |